![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Wykretowicz Andrzej Guzik Przemyslaw Wysocki Henryk
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.9, Iss.4, 2008-03, pp. : 625-633
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chlorthalidone superior to doxazosin in hypertension
Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Doxazosin cost effective for hypertension in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Doxazosin cost effective for hypertension in diabetes
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Treatment of Patients with Hypertension: Therapeutic Implications of INSIGHT
By Taddei S. Ghiadoni L. Salvetti A.
Drugs, Vol. 63, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Acute Severe Hypertension: Current and Newer Agents
By Varon Joseph
Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. :